1 position(s) for Worldwide Medical Immunology & Fibrosis (I&F) / Medical Evidence Generation (MEG)
Fellowship Position Office Location: Lawrenceville, NJ 08648
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, offers innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and bio-pharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships and Bristol Myers Squibb. The Worldwide Medical Immunology & Fibrosis (I&F) / Medical Evidence Generation (MEG) position is a two-year fellowship that will provide a unique opportunity to gain expertise in multiple dimensions of the medical affairs function in the immunology space, specifically in immune diseases in gastroenterology and dermatology.
The Fellow will be involved with the development and implementation of global medical strategies for the assets/indications under his/her responsibilities, with a particular focus during the 2nd year on the development and implementation of the Integrated Evidence Plan (IEP) and interaction with the different modalities of evidence generation (investigator-sponsored studies, interventional and non-interventional company-sponsored trials, collaborative research, data mining and exploratory analysis among others).
During the fellowship, the candidate is expected to participate in multiple important events including phase II and III study read-outs, design and implementation of Phase IIIb/IV studies, and preparation for global launch(es).
Fellows will collaborate and be part of a cross-functional matrix (including publications, field medical, clinical development, regulatory, health economics and outcome research, commercial, market access), allowing a holistic view of the medical affairs scope and areas of impact during a product lifecycle.
University-based experiences include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and bio-pharmaceutical industry as future leaders. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the Request Interview button to the right. We do not pre-schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
The RPIF program will be conducting initial interviews on a rolling basis virtually (video/teleconference) from October 10th through November 23rd. Candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below. Please see our website for additional important recruitment information and dates.
Once all interviews have been completed, the company will notify candidates of their position-specific candidacy status.
Create an RPIF Candidate Account starting September 23, 2022.
Upload RPIF Application Materials to RPIF Candidate Account starting September 23, 2022.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Upload your Letter of Intent and Curriculum Vitae (CV) by October 5, 2022.
Begin securing letters of recommendation because all 3 must be received before you could be considered for an offer. Submit all 3 letters of recommendation by November 10, 2022.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
It is university policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay, fringe benefits, layoff, termination or any other terms and conditions of employment. For additional information please see the Non-Discrimination Statement at the following web address: http://uhr.rutgers.edu/non-discrimination-statement
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.